Literature DB >> 26694912

Anterior segment parameters and eyelids in systemic sclerosis.

Sevinc Sahin Atik1, Feray Koc2, Sirin Akin Sari3, Nazife Sefi Yurdakul2, Mustafa Ozmen4, Servet Akar4.   

Abstract

To evaluate main numerical parameters of anterior segment and the effects of eyelid skin changes on these parameters in patients with systemic sclerosis (SSc). Thirty-four patients with SSc and 34 healthy individuals were enrolled. Besides full eye examination, anterior segment measurements including anterior chamber depth (ACD), anterior chamber volume, anterior chamber angle width, central corneal thickness, pupil size, corneal volume and keratometry were obtained using a Sirius Scheimpflug/Placido photography-based topography system. Eyelid thickness was evaluated using the scala of the modified Rodnan skin score and the patients were subgrouped with respect to these scores to evaluate the effect of eyelid thickening on the anterior segment parameters. Age and sex distributions of the groups were similar (p > 0.05). SSc patients had steeper and thinner corneas, smaller corneal volumes, narrower, shallower and smaller anterior segments but only the mean ACD value of right eyes was found significantly less than those of the controls (p = 0.047). The mean ACD values of SSc subgroup patients with moderate to severe eyelid thickening (50 %) had lower ACD measurements compared to those of control group. (p = 0.043 for the right eyes, p = 0.070 for the left eyes). However, SSc subgroup patients with none to mild eyelid thickening (50 %) had similar anterior segment parameters with control subjects (p > 0.05). Anterior chamber parameters of the SSc patients could show significant differences. These differences occur parallel to the eyelid changes but not secondary to it.

Entities:  

Keywords:  Anterior chamber depth; Anterior segment parameters; Eyelid thickness; Systemic sclerosis

Mesh:

Year:  2015        PMID: 26694912     DOI: 10.1007/s10792-015-0165-4

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  26 in total

1.  Elevated intra-ocular pressure after sub-Tenon's anaesthesia in systemic sclerosis.

Authors:  M R Edmunds; I Kyprianou; K N Amissah-Arthur; G Smith
Journal:  Anaesthesia       Date:  2010-03       Impact factor: 6.955

Review 2.  Calculation of intraocular lens power: a review.

Authors:  Thomas Olsen
Journal:  Acta Ophthalmol Scand       Date:  2007-04-02

3.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

4.  Comparison of anterior segment parameters between the acute primary angle closure eye and the fellow eye.

Authors:  Jong Rak Lee; Kyung Rim Sung; Seungbong Han
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-20       Impact factor: 4.799

5.  Ocular involvement in a case of scleroderma.

Authors:  R Anand
Journal:  Indian J Ophthalmol       Date:  1985 Jan-Feb       Impact factor: 1.848

Review 6.  Ocular manifestations of scleroderma.

Authors:  Rajen Tailor; Abha Gupta; Ariane Herrick; Jeffrey Kwartz
Journal:  Surv Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 6.048

Review 7.  Collagens and collagen-related matrix components in the human and mouse eye.

Authors:  Tapio Ihanamäki; Lauri J Pelliniemi; Eero Vuorio
Journal:  Prog Retin Eye Res       Date:  2004-07       Impact factor: 21.198

Review 8.  Abnormal B lymphocyte activation and function in systemic sclerosis.

Authors:  Ayumi Yoshizaki; Shinichi Sato
Journal:  Ann Dermatol       Date:  2015-02-03       Impact factor: 1.444

9.  Prevalence of ocular manifestations in systemic sclerosis patients.

Authors:  Arleta Waszczykowska; Roman Goś; Elżbieta Waszczykowska; Bożena Dziankowska-Bartkowiak; Piotr Jurowski
Journal:  Arch Med Sci       Date:  2013-11-29       Impact factor: 3.318

10.  Comparison of Anterior Segment Measurements with Scheimpflug/Placido Photography-Based Topography System and IOLMaster Partial Coherence Interferometry in Patients with Cataracts.

Authors:  Jinhai Huang; Na Liao; Giacomo Savini; Fangjun Bao; Ye Yu; Weicong Lu; Qingjie Hu; Qinmei Wang
Journal:  J Ophthalmol       Date:  2014-10-23       Impact factor: 1.909

View more
  4 in total

1.  A multimodal ophthalmic analysis in patients with systemic sclerosis using ocular response analyzer, corneal topography and specular microscopy.

Authors:  Huseyin Mayali; Muhammed Altinisik; Secil Sencan; Timur Pirildar; Emin Kurt
Journal:  Int Ophthalmol       Date:  2019-09-28       Impact factor: 2.031

2.  Is there an association between glaucoma and capillaroscopy in patients with systemic sclerosis?

Authors:  Beatriz Fiuza Gomes; Rebeca Souza; Thiago Valadão; Newton Kara-Junior; Haroldo Vieira Moraes; Marcony R Santhiago
Journal:  Int Ophthalmol       Date:  2017-05-06       Impact factor: 2.031

Review 3.  Ocular manifestations in patients with systemic sclerosis.

Authors:  Małgorzata Kozikowska; Wojciech Luboń; Eugeniusz J Kucharz; Ewa Mrukwa-Kominek
Journal:  Reumatologia       Date:  2020-12-23

4.  An in vivo confocal microscopy study of corneal changes in patients with systemic sclerosis.

Authors:  Eszter Szalai; Gabriella Szucs; Szilvia Szamosi; Zsuzsa Aszalos; Ildiko Afra; Adam Kemeny-Beke
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.